Vivo Opportunity, LLC, 10% Owner at Terns Pharmaceuticals, Inc. (TERN), bought 600,000 shares at $3.60 ($2.2M) on 2022-09-07, disclosed to the SEC on 2022-09-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| INM | BUY | 2026-06-10 | $392K | — | Filing → |
| SLNO | SELL | 2024-08-29 | $49.2M | — | Filing → |
| TERN | SELL | 2024-04-03 | $4.9M | — | Filing → |